Now showing items 1-1 of 1

    • Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women 

      Ruiz-Sternberga, Ángela María; Moreira Jr, Edson D.; Restrepo, Jaime A.; Lazcano-Ponce, Eduardo; Cabello, Robinson; Silva, Arnaldo; Andrade, Rosires; Revollo, Francisco; Uscanga, Santos; Victoria, Alejandro; Guevara, Ana María; Luna, Joaquín; Plata, Manuel; Nossa Dominguez, Claudia; Fedrizzi, Edison; Suarez, Eugenio; Reina, Julio C.; Ellison, Misoo C.; Moeller, Erin; Ritter, Michael; Shields, Christine; Cashat, Miguel; Perez, Gonzalo; Luxembourg, Alain
      Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. Methods: Efficacy, ...
       Artículo. 2018

       

      Reconocimientos: